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ABSTRACT This review describes a framework for providing a personalised approach to selecting the
most appropriate airway clearance technique (ACT) for each patient. It is based on a synthesis of the
physiological evidence that supports the modulation of ventilation and expiratory airflow as a means of
assisting airway clearance. Possession of a strong understanding of the physiological basis for ACTs will
enable clinicians to decide which ACT best aligns with the individual patient’s pathology in diseases with
anatomical bronchiectasis and mucus hypersecretion.
The physiological underpinning of postural drainage is that by placing a patient in various positions,
gravity enhances mobilisation of secretions. Newer ACTs are based on two other physiological premises:
the ability to ventilate behind obstructed regions of the lung and the capacity to achieve the minimum
expiratory airflow bias necessary to mobilise secretions. After reviewing each ACT to determine if it
utilises both ventilation and expiratory flow, these physiological concepts are assessed against the clinical
evidence to provide a mechanism for the effectiveness of each ACT. This article provides the clinical
rationale necessary to determine the most appropriate ACT for each patient, thereby improving care.
Introduction
Personalised medicine has been used to describe the application of genomics, proteomics and biomarkers to
precisely tailor therapy according to various characteristics of an individual patient [1]. This concept of
personalised medicine can also be applied to a variety of therapies, such as airway clearance, by taking into
account individual patients’ lung pathology, clinical, functional, environmental and social factors, as well as
the physiological concepts underlying airway clearance techniques (ACTs) [2]. Personalised medicine
results in resources being more effectively directed to the most appropriate patients, thereby ensuring that
patients receive the specific techniques that optimise the likelihood of benefit in terms of lung health and
time commitment. The use of ACTs can be further enhanced by the appropriate use of inhaled medications
such as mucoactive agents; however, these medications are not within the scope of this review [3].
This article provides an overview of the physiological principles underlying ACTs and links these
physiological principles to the evidence base of commonly used ACTs. This will help clinicians to
personalise airway clearance techniques specific to patients’ underlying lung pathology as well as other
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clinical, functional, environmental and social factors. While some patients with chronic lung disease are
ventilated, the vast majority breathe spontaneously. As the physiological mechanisms described differ in
ventilated patients, it must therefore be emphasised that this review only describes the spontaneously
breathing patient [4].
Background
ACTs are used to supplement the body’s mucociliary clearance system when it is impaired by disease. This
system is an important lung defence mechanism consisting of airway surface liquid comprising mucus and
periciliary layers (PCLs), ciliary epithelium and cough clearing mechanisms [5]. In healthy people, cilia
beat at a mean frequency of 11–13 Hz [6], propelling mucus proximally up the airways at a rate of 4–
5 mm·min-1 [7, 8]. The rate of clearance is strongly influenced by the hydration state, rigidity and viscosity
to elasticity ratio of the mucus [9, 10].
The mucociliary transport system is impaired in chronic suppurative lung diseases, such as cystic fibrosis
(CF), primary ciliary dyskinesia (PCD) and bronchiectasis not caused by CF. This is due to the occurrence
of one or more of the following conditions: dehydration of the PCL; absence of lubricant activity which
prevents adhesion of mucus to airway surfaces [11]; an inherent defect within the cilia; or
immunodeficiencies, including cellular defects. Any one of these may cause a failure of ciliary beat
frequency and reduced mucociliary clearance. Once this mechanical defence system is breached, the lung is
more susceptible to infection and inflammation that can result in further airway damage, eventually
leading to bronchiectasis [12].
To be effective, ACTs should assist the body’s natural mucociliary clearance system to transport secretions
proximally up the airways. Historically, to achieve mucociliary clearance, postural drainage positions were
utilised primarily for drainage by relying on gravity [13]. However, there is little supporting evidence that
postural drainage utilising gravity effectively mobilises secretions [14, 15]. In CF patients, gravity in a
head-down position increased the mucociliary clearance rate only from 0 mm·min-1 to 3–5 mm·min-1 [8].
Based on the assumption that mucociliary clearance rates in gravity dependent positions remain the same
in different lung regions, to mobilise secretions from a subsegmental airway in the lower lobe would
require a patient to be placed in a head-down position for ∼1 h. Thus, positioning a patient in a
head-down position for 3–5 min (as historically used in CF centres) is expected to be ineffective and may
even do harm by promoting gastro-oesophageal reflux [13, 16–20]. Two studies, one in CF adults and the
other in patients with chronic bronchitis using radiolabeled tracer gases demonstrated that in the
side-lying position more secretions are mobilised from the dependent lung than from the nondependent
lung, which suggests that the impact of body position on ventilation plays a greater role than gravity in
mobilising secretions [21–23]. Since these data were published there has been limited translation of these
findings into clinical practice, which is perhaps why in many countries, positioning for drainage remains a
key ACT. Positioning for ventilation is discussed later.
Newer ACTs rely on two overriding physiological principles. First, a mechanism to allow air to move
behind obstruction and ventilate the regions distally and second, modulation of expiratory airflow in such
a way as to propel secretions proximally up the airways. We describe the physiological theories and
evidence underlying the use of individual ACTs in the nonventilated spontaneously breathing patient.
Principles for optimising ventilation to obstructed regions of the lung
In normal healthy individuals, during inspiration, airflow takes the path of least resistance, ventilating all
areas of the lung, although there may be some asynchronous ventilation secondary to regional and
stratified inhomogeneity [24]. In patients with obstructed airways, secretions decrease the diameter of the
airway and increase airway resistance, causing preferential ventilation of unobstructed regions and
hypoventilation of obstructed regions [24]. Over time, air gradually moves behind the obstruction, but it is
not expired, leading to dynamic hyperinflation of the obstructed lung unit. Several mechanisms used in
ACTs optimise ventilation to obstructed lung units.
Interdependence during deep inspiration
When tidal volume is increased during a deep inspiration, expanding alveoli exert a traction force on the
less well expanded alveoli they surround, thereby assisting in the re-expansion of collapsed alveoli due to
the elasticity of the surrounding interstitium. This is known as “interdependence”. It results in air moving
into the small airways obstructed by secretions, a phenomenon that has been called Pendelluft [25] and
which results from the interdependence. The theory of interdependence was proposed by MEAD et al. [26]
and a physical model was created to test this hypothesis. The theory was later confirmed in clinical studies
on anaesthetised dogs [27].
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Collateral ventilation
Ventilation can also occur between adjacent lung segments through collateral channels [28, 29]. In healthy
individuals, the importance of collateral ventilation is negligible, due to resistance to airflow being higher
in the collateral channels than in the airways. However, if an airway proximal to these collaterals becomes
blocked, the collateral channels allow air to move through these pathways due to the pressure differences
between adjacent lung units and function to minimise collapse of lung units. Studies have shown that
excised human lungs can be re-inflated using collateral channels [30, 31]. There are three types of
collateral connections: channels of Lambert, pores of Kohn and pathways/channels of Martin.
Channels of Lambert represent epithelium-lined tubular communications between distal bronchioles and
the adjacent alveoli. These are probably the primary channels responsible for collateral ventilation [32].
Pores of Kohn are interalveolar connections. There are ∼50 pores of Kohn, varying from 3 to 13 µm in
diameter in each alveolus [33, 34]. In vivo, these pores are mostly filled by fluid and act as a pathway for
alveolar lining fluid, surfactant components and cells such as macrophages to move between adjacent
alveoli [34]. The pathways/channels of Martin are interbronchiolar connections. Results of an experiment
with excised dog lungs, pressurised to 17–28 cmH2O indicated connections between respiratory
bronchioles and terminal bronchioles from adjacent lung segments [35], suggesting that use of collateral
ventilation channels forms the basis for use of positive expiratory pressure (PEP) ACTs.
3-s breath hold
A 3-s breath hold is another method of ventilating obstructed lung units. When the unobstructed region
of the lung has been preferentially ventilated, a pause for 3 s alters the time constants and allows air to
move from the unobstructed regions, where the pressure gradient is higher, to the obstructed regions of
the lung. This transient movement of gas out of some alveoli into others at the end of inspiration is
known as Pendelluft flow. Multiple-breath washout tests have shown that a breath hold increases alveolar
gas mixing and decreases the inhomogeneity of ventilation in normal subjects [36]. In post-operative
clinical practice it has been demonstrated that a 3-s breath hold is effective in reducing atelectasis [37].
Positioning to optimise ventilation in adults and children
Positioning may be used to enhance ventilation to specific lung regions where secretions are located, such
as in bronchiectasis patients. The increased ventilation to those lung regions can then be used effectively to
mobilise secretions [21, 22]. There are differences in chest shape and lung mechanics between adults and
children which result in differences in ventilation patterns.
When adults are placed in the upright position, optimum ventilation occurs in the mid and lower lobes,
while perfusion is greatest in the lower lobes. Theoretically, ventilation/perfusion ratio is 1 at the level of
the right middle lobe and lingula [38]. When an adult is placed in a side-lying position, the dependent
lung is preferentially ventilated due to the dependent hemi-diaphragm being stretched, causing a greater
length to tension ratio, with increased contractility. This creates a greater negative pleural pressure, which,
clinically, results in increased ventilation [39]. Perfusion is greater to the dependent lung in both adults
and children because it is gravity dependent.
When very young children are placed in the side-lying position, the nondependent lung is preferentially
ventilated, probably due to the differences in lung and chest wall mechanics. This occurs in children
aged <12 years, causing airway closure to occur in the more dependent regions, independent of lung
disease [39].
Supine is the best position to ventilate the upper lobes [38]. However, if this is not suitable, as when taking
an inhaled medication, side lying may be an alternative position. Inhaled drug deposition is improved by
13% to the dependent upper lobe when healthy adults were placed in the side-lying position. Adults with
mild CF lung disease improve upper lobe deposition by 4% with the same side-lying strategy [40]. Table 1
shows optimal positioning for use during airway clearance to optimise ventilation to obstructed regions of
the lung, based on changes in ventilation patterns with positioning.
Use of mobilisation to increase ventilation
Moving a patient into different positions affects ventilation in two different ways. First, a change in body
position alters regional ventilation as noted above. Second, by increasing the mobility of a patient, oxygen
demand increases, resulting in a corresponding increase in minute ventilation and lung volumes [41]. The
resultant increase in ventilation allows air to move into obstructed lung units by interdependence and
collateral ventilation.
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Methods of utilising expiratory airflow to enhance secretion removal
Increasing the velocity of the expiratory airflow in such a way as to create high shearing forces at the
airway walls, and high kinetic energy that enhances the cephalad movement of secretions is a second key
mechanism to mobilise airway secretions.
Cough
Coughing is a normal reflex defence mechanism used to clear excessive secretions down to the 7th or 8th
generation of airways [42]. During a typical cough, a deep inspiration is followed by closure of the glottis.
High intrathoracic pressure (up to 300 mmHg) builds up, resulting in a high explosive, turbulent
expiratory flow rate that may exceed 500 L·min-1 [43] when the glottis is opened. During this time,
dynamic compression of the airways occurs, resulting in an increase in velocity and kinetic energy which
produces a shear force detaching mucus from the airway walls and enhancing the cephalic movement of
mucus proximally up the airways. Distal to the regions where the airways are compressed, there may be a
collapse of the airways, especially when airway instability is present [43].
Cough is an effective method of clearing secretions from the larger airways in healthy individuals.
However, in chronic supperative lung disease, where narrowing and “floppy” airways may close
prematurely, it can have detrimental effects if used inappropriately over an extended period as the primary
method of clearing secretions. When repeated coughs are used, bronchial wall instability may result from
recurrent compression of the airways, thereby reducing expiratory flow and limiting the effectiveness of the
cough [44]. Therefore, we recommend that ACTs be used as the primary method of mobilising secretions
from the middle and small airways to the larger airways. Then one effective cough be used to clear
secretions from the larger airways, thereby preserving the integrity of the larger airways.
Huff/forced expiratory manoeuvre
A forced expiration manoeuvre may also be described as a “huff”. It accelerates the expiratory airflow,
creating high linear velocities that shear mucus from the airway walls. Unlike a cough that is performed
with a closed glottis, a huff is performed with an open glottis. The huff concept is based on the equal
pressure point (EPP) theory [45]. At the EPP, dynamic compression of the airways occurs, creating an
increase in the linear velocity of the expiratory airflow which propels secretions proximally. The site of the
EPP is determined by the size of expiratory force, airway stability and the elastic recoil. Initiating a forced
expiration at a low lung volume shifts the EPP to the periphery, targeting secretions in the small airways.
Similarly, initiating a forced expiration from a high lung volume will move the EPP centrally towards the
thoracic aperture. This is sometimes referred to as a “huff-cough” [38].
Two-phase gas-liquid flow mechanism
Mucus clearance can be modelled as a two-phase gas-liquid flow mechanism [46]. This indicates that peak
expiratory flow rate (PEFR) must exceed peak inspiratory flow rate (PIFR) by ⩾10% for mucus to move
proximally. The PEFR must also exceed 30–60 L·min-1 to overcome the adhesive strength by which the
mucus is attached to the interface. Mucus factors affecting mucociliary clearance are the mucus depth and
the viscoelastic properties of mucus. Viscosity is a liquid property of mucus, whereas elasticity is described
as the energy storage with an applied stress to a solid. The rate of mucus transport is higher with
viscoelastic mucus than with nonelastic viscous mucus [47].
During normal tidal volume breathing at rest, PEFR is not >30 L·min-1 and PIFR is greater than PEFR.
The result is that secretions are not mobilised. In order to use airflow to mobilise secretions it is necessary
to optimise the expiratory airflow so that PEFR>PIFR by ⩾10%, and the velocity of the expiratory flow
TABLE 1 Optimal positioning for airway clearance techniques to enhance ventilation to
obstructed regions of the lung
Optimal position Alternative, second-choice position
Secretions in upper lobes Supine Side lying
Secretions in middle lobe and lingula Upright Side lying or supine
Secretions in right lung Adults: right-side lying
Children: left-side lying
Secretions in left lung Adults: left-side lying
Children: right-side lying
Secretions in lower lobes Upright Side lying
https://doi.org/10.1183/16000617.0086-2016 4
AIRWAY CLEARANCE | M. MCILWAINE ET AL.
rate is ⩾30–60 L·min-1, depending on the properties of the secretions. In a clinical study that examined the
effect of a cough and a huff on regional lung clearance, mean PEFR recorded with a cough was 288
±29 L·min-1 and 203±25 L·min-1 with a huff [48]. Both were sufficient to increase tracheobronchial
clearance by 44% and 42%, respectively, confirming that an increase in PEFR will enhance lung clearance
[48]. Further studies have demonstrated that, in addition to huffing and coughing, manual vibration,
oscillating PEP (using the Flutter VRP1; VarioRaw, Aubonnie, Switzerland) and autogenic drainage met
the criteria for using expiratory flow to mobilise secretions proximally [49, 50] (table 2).
Effects of expiratory airflow on airway surface liquid
Studies have been conducted on the effect of airflow on the volume of airway surface liquid (ASL), using
an oscillatory motion device and a cyclic compressive device [47, 52]. The use of these devices caused
normal airway cell cultures to double their ASL height with oscillatory motion of 0.3–0.4 Hz, and CF
cultures to increase their ASL height to ∼7 µm, thereby becoming capable of maintaining mucus transport
for protracted intervals. It is hypothesised that oscillatory shear stress stimulates ATP, which in turn
stimulates calcium-mediated chlorine secretion and inhibits sodium absorption.
These important physiological findings provide some basis for the use of airway clearance techniques
utilising expiratory airflow and pressure support. However, the oscillation rate of 0.3–0.4 Hz, which is
defined in these experiments, is only slightly greater than the rate of breathing in an adult, and does not
equate to the oscillation rate of 11–15 Hz described later as the oscillation rate necessary for effective
airway clearance. Further studies are needed to confirm these in vitro experiments.
Oscillation
Oscillation frequencies of 5–17 Hz improve tracheal mucus clearance rates in dogs, with frequencies of 11–
15 Hz increasing mucus clearance from 8.2 mm·min-1 to 26 mm·min-1 [53], which corresponds to the ciliary
beat frequency. In addition, oscillations have an effect on the mucus rheological properties of mucus rigidity
(sum of viscosity and elasticity), spinnability (thread forming capacity of mucus) and a derived cough
clearance index (CCI). A higher CCI indicates that the mucus is easier to clear with a cough. In an in vitro
study, oscillations at 19 Hz using an oscillatory PEP device (Flutter VRP1) resulted in only a small
nonsignificant decrease in mucus rigidity and no significant change in the CCI [54]. The use of recombinant
human (rh)DNase had the same effect. However, when oscillations were combined with rhDNase the result
was a significant decrease in rigidity and a significant change in the CCI. A 4-week clinical study confirmed
the findings from the in vitro study and demonstrated a significant decrease in sputum rigidity and
spinnability following oscillation with the Flutter compared to autogenic drainage [55]. In another study of
CF patients who exercised for 20 min on a treadmill, there was also a significant reduction in sputum
rigidity [56]. This result may be due to trunk oscillations associated with treadmill exercise.
Vibrations
Vibrations are the application of fine manual oscillatory movements (either back and forth or side to side)
applied to the chest wall during expiration. In studies of healthy subjects vibrations increase PEFR by 50%
over relaxed expiration [57, 58]. The frequency of vibration and its effect on expiratory airflow has been
compared to several other airway clearance interventions in clinical studies: Acapella (Smiths Medical
International, Hythe, UK), PEP, Flutter and percussion [49]. Vibration was applied during expiration after
a slow maximal inspiration (table 2). The resultant PEFR of 94.8 L·min-1 and PEFR/PIFR ratio of 1.51
were sufficient to assist in mucus clearance and were greater than the other interventions, but lower than a
TABLE 2 Effects of airway clearance interventions on peak flow rates
Subjects n PEFR L·min-1 PIFR L·min-1 PEFR/PIFR ratio Frequency Hz
Huff 17 302.4±121.8 124.8±85.2 2.80
Cough 17 280.2±114.6 100.8±44.4 3.07
Vibration 17 94.8±43.8 63.6±16.2 1.51 8.4±0.4
Autogenic drainage 14 85.2±28.8 50.4±13.8 1.69
Flutter 17 67.8±18.0 63.0±16.2 1.15 11.3±1.5
Percussion 18 49.8±8.4 50.4±6.0 0.99 7.3±0.3
Acapella 18 35.4±4.8 58.8±16.2 0.64 13.5±1.7
PEP 18 26.4±9.0 57.6±12.0 0.47
Data are presented as n or mean±SD. Data from [49–51]. PEFR: peak expiratory flow rate; PIFR: peak inspiratory flow rate; PEP: positive
expiratory pressure.
https://doi.org/10.1183/16000617.0086-2016 5
AIRWAY CLEARANCE | M. MCILWAINE ET AL.
huff or cough manoeuvre [49]. This work has added greatly to our understanding of the effects of
vibration, particularly its impact on expiratory flow rates. In addition, based on studies demonstrating that
oscillation frequencies of 5–17 Hz improve mucociliary clearance [52], there is a sound rationale to suggest
that vibrations with a frequency of <17 Hz will improve mucociliary transport [49, 58].
Applying physiological principles to airway clearance techniques
In order to determine which ACT is most suitable for the individual patient, it is important to understand
how each ACT incorporates the physiological elements of ventilation and expiratory airflow, as described
earlier. Both are essential for enhancing mucus clearance. Table 3 gives a synopsis of the physiological basis
for each ACT followed by a more detailed outline of their physiological components. The ACTs included in
this section are evidence based and have randomised controlled long-term clinical trials to support their
use. There are other ACTs and ACT devices in use, and which are currently being researched, but they have
not been included in this review as they lack the rigour of evidence from long-term studies.
Active cycle of breathing techniques
The active cycle of breathing techniques (ACBT) ventilates behind obstructed lung units, using
interdependence and collateral ventilation, during thoracic expansion exercises [59]. A 3-s breath hold is
included at the end of inspiration. This increases alveolar gas mixing and decreases the inhomogeneity of
ventilation [36] (table 3). The main driver of expiratory airflow is huffing, which relies on the use of EPP
to enhance mucus clearance. The peak expiratory flow rate, with a huff at high lung volume, is similar to a
cough (table 2), demonstrating that the increase in air flow linear velocity is sufficient to promote cephalic
movement of secretions [60]. Both the breathing level at which the huff is performed and the strength of
the huff are adjusted to allow the EPP to occur where the secretions are located. As huffing is a forced
expiration manoeuvre, which can lead to bronchospasm, it is necessary to intersperse it with breathing
control, i.e. the forced expiration technique, which is a combination of huffing and breathing control [61].
ACBT is performed in either upright, recumbent or drainage positions [60].
Autogenic drainage
In autogenic drainage, ventilation to obstructed lung regions is achieved using a 3-s breath hold on
inspiration during tidal volume breathing, utilising the collateral ventilation channels. The expiratory airflow
is modulated so that at each level (unsticking phase, collecting phase and evacuating phase), tidal volume
breathing is performed and the expiratory airflow velocity is maximised without causing dynamic
compression of the airways (figure 1) [43, 62]. In a study with patients who had obstructive lung disease,
when autogenic drainage was performed, the expiratory airflow varied in the range 40–70 L·min-1 depending
on lung volume and level of breathing, thereby moving secretions proximally [50]. A slow inspiratory flow
rate is necessary to create an expiratory flow rate bias by ⩾10%. Autogenic drainage is usually performed in
an upright position; an alternative position may be used to enhance ventilation to specific lung regions.
PEP mask
This is a flow-regulating technique employing PEPs of 10–20 cmH2O [63, 64]. Functional residual capacity
(FRC) is temporarily increased by breathing through a closed system using a PEP mask (figure 2) [65].
Usually PEP is performed in a sitting position and the patient is instructed to take 12–15 tidal volume
breaths through the PEP mask before it is removed for huffing [66]. If the patient removes the mask
prematurely, before completing 12 breaths, or uses a mouthpiece without a good seal, the positive pressure
in the airways is lost and FRC returns to normal, thereby lessening the effect of the technique. The effect
of an application of PEP on collateral channels was demonstrated by MARTIN [35]. The PEP technique uses
a pressure similar to that used in studies on the effect of pressure on ASL [47, 52]. Therefore, it may also
enhance mucociliary transport by increasing ASL.
While ventilation is improved through the use of the PEP mask, the expiratory airflow necessary to
mobilise secretions proximally is not achieved, as PEP only has a PEFR/PIFR of 0.47 [49]. Therefore, PEP
must be combined with a manoeuvre such as huffing or autogenic drainage.
Oscillating PEP
Flutter and Acapella devices generate an automatically controlled oscillating PEP, although both utilise
different physiological bases. They provide similar frequency of oscillation within the range necessary to
decrease the viscoelastic and spinnability properties of mucus, and thereby improve mucus clearance [53,
55.] Flutter oscillates with frequencies 15–29 Hz, with average PEPs of 5–19 cmH2O. Acapella oscillates
with frequencies of 13–30 Hz, with an average pressure of 6–21 cmH2O [67]. These oscillation frequencies
are much higher than the 0.3–0.4 Hz [47, 52] used in the in vitro experiments in which ASL height was
doubled. The effect of frequencies of 6–26 Hz on ASL are still to be determined.
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TABLE 3 Physiological basis for each airway clearance technique
Ventilation Expiratory airflow Oscillation
Interdependence CV Breath hold Huffing# PEFR/PIFR >1.1 PEFR >30–60 L·min-1
Active cycle of breathing
techniques
Thoracic expansion
exercises utilise
interdependence
Thoracic expansion
exercises utilise CV
Sometimes used with
this technique if
hypoventilating
Uses forced
expirations at
different levels
Ratio 2.8 Average 302 L·min-1
with huffing
No
Autogenic drainage No Yes, with breath
hold
Uses 3-s breath hold
with each breath
Only used to clear
secretions from
larger airways if
needed
Yes; emphasis is
on slow
inspiration and
increased velocity
on expiration
40–70 L·min-1 Depends
on level of breathing and
degree of airway
obstruction
No
PEP No As PEP is
maintained within
the airways over
12–15 breaths, use
of CV is maximised
Not necessary as
PEP is maintained
within the airways
over 12–15 breaths
Used at end
of each cycle of
12–15 breaths
No
Ratio 0.47
No
Average 26 L·min-1
No
Oscillating PEP with
Flutter
Oscillations at 3–5 Hz
may play a role, but
frequency used in
Flutter is >5 Hz
Yes with breath hold Uses 3-s breath hold
with each breath
Used at end of
each cycle of 8–10
breaths
Ratio 1.15 Average 68 L·min-1 2–32 Hz
Most often
uses 6–26
Hz
Oscillating PEP with
Acapella
Oscillations at 3–5 Hz
may play a role, but
frequency used in
Acapella is >5 Hz
As a PEP is
maintained within
the airways over 12–
15 breaths, use of
CV is maximised
Not necessary Used at end of
each cycle of
12–15 breaths
No
Ratio 0.64
Average 35.4 L·min-1
Within PEFR range
needed, but would
depend on viscoelastic
and viscosity properties
of secretions
10–18 Hz
HFCWO Oscillations at 3–5 Hz
may play a role, but
frequency used in
HFCWO is >5 Hz
No No Interspersed with
HFCWO
Yes, expiratory
flow rate is much
higher than
inspiratory flow
rate
Average 120 L·min-1 5–25 Hz
CV: collateral ventilation; PEFR: peak expiratory flow rate; PIFR: peak inspiratory flow rate; PEP: positive expiratory pressure; HFCWO: high-frequency chest wall oscillation. #: each
technique incorporates huffing, as used in the forced expiration technique, with the exception of autogenic drainage.
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Oscillating PEP with Flutter
While exhaling through the Flutter device to expiratory reserve volume (ERV), the individual tunes the
device to their ventilatory ability, thereby enabling a modulation of both pressure and airflow oscillation
frequency, increasing expiratory airflow, to mobilise secretions proximally [68]. Flutter produces an
expiratory flow bias of PEFR/PIFR of 1.15, which is sufficient to mobilise secretions [49]. In addition,
huffing is added at the end of each breathing cycle. Unlike the PEP mask, FRC is not increased with the
Flutter due to the inability to inspire through the device. To overcome ventilatory asynchronism,
inspiration is followed by a 3-s breath hold.
While the Flutter meets the two criteria for mobilising secretions, it raises some concerns. Sometimes,
expiration is into the ERV, where closing volume has the potential to cause airway closure [69]. FRC level
is not temporarily increased so that the effect of PEP on opening collateral channels is negated. However,
the 3-s breath has been shown to increase alveolar gas mixing, alter time constants and allow air to move
distal to any obstruction. Another limitation of the Flutter is that due to its pipe-like design, it can only be
used in the upright position.
Oscillating PEP with Acapella
Because inspiratory and expiratory manoeuvres are performed through the Acapella in a closed system for
12–15 breaths, its physiological basis is similar to the PEP technique, allowing air to move behind secretions
Predicted values
Obstructive values
TV
TV
Unstick Collect Evacuate
Huff
ERV
ERV
RV
RV
FIGURE 1 Breathing pattern during autogenic drainage. TV: tidal volume; ERV: expiratory reserve volume; RV:
residual volume.
Opening volume
Closing volume
TLC
FRC
RV
Healthy = predicted 
volumes
Obstructed,
hyperinflated
FET at different
lung volumes
Slightly active TV breathing 
towards an expiratory 
resistor
Cough
FIGURE 2 Schematic representation of breathing levels during positive expiratory pressure in an obstructed
patient. TV: tidal volume; FET: forced expiration technique; TLC: total lung capacity; FRC: functional residual
capacity; RV: residual volume. Courtesy L. Lannefors (Sahlgrenska University Hospital, Gothenburg, Sweden).
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through collateral ventilation channels as a result of an increased FRC level. The addition of oscillation
should enhance the technique. Similar to PEP, the expiratory flow bias is insufficient with a PEFR/PIFR ratio
of 0.64 [49], therefore the Acapella needs to be combined with huffing to assist in mucociliary clearance
from the larger airways. Acapella is position independent, so it can be used in any position to optimise
ventilation.
High-frequency chest wall oscillation
During high-frequency chest wall oscillation (HFCWO) (also described as high-frequency chest
compression), oscillations are created over the chest wall at frequencies of 5–25 Hz. On expiration the
oscillations enhance mucociliary transport in three essential ways, similar to the oscillations produced with
oscillatory PEP devices: 1) by altering the rheological properties of mucus [54]; 2) by creating an
expiratory flow bias that shears mucus from the airway walls and encourages its movement proximally
[53]; and 3) by enhancing ciliary beat frequency [70]. The oscillatory expiration flow generated by
compression of the chest wall (creating a PEFR <120 L·min-1) is sufficient to overcome mucus adhesion
from the airway wall and propel it up the airway. However, the HFCWO device provides no means of
ventilating behind obstructed airways. Unlike the other oscillatory devices, HFCWO does not provide any
PEP, and the end-expiratory volume has been reported to decrease by 10–50% during compression [71].
While this may improve expiratory flows through the smaller airways, it may worsen expiratory flows if
the airways are smaller and airway resistance is increased, leading to early airway closure [72]. This may
lead to a worsening of lung disease. Several short-term randomised controlled trials in CF patients have
been unable to demonstrate any significant difference between HFCWO and other ACTs [73–76].
However, in two long-term studies, HFCWO was associated with an increased number of respiratory
exacerbations in one [77] and by a decreased in lung function in the other [78].
Personalising airway clearance strategies
While no one ACT has been found to be more effective than another, as synthesised in five Cochrane
reviews [79–83] on ACTs in CF, traditionally the choice of ACT has been based on what is available
locally, the training and expertise of the local physiotherapist and culture [84]. However, a one-size fits all
approach based on regional preference may not address specific patient needs. An individualised strategy
should take into account the patient’s disease state, preference, motivation and maturity, which, together
with the physiological knowledge base of each ACT, applies the most effective airway clearance
intervention for that individual. Some examples of clinical considerations based on the unique
physiological principles of each ACT are as follows.
1) A deep inspiration with a 3-s breath hold is a particularly effective means of increasing ventilation in
patients with a restrictive component to their lung disease [37], but using a 3-s breath hold in a patient
with a severe lung disease who is tachypnoeic may lead to hypoxia.
2) A forced expiration, as used in ACBT and with the various PEP devices, needs to be adapted to the
individual’s underlying lung pathology. In a patient with collapsible airways, a huff may compress the
airways in such a way as to limit expiratory airflow rather than to increase the velocity of airflow [43].
Alternatively, if bronchospasm is present, airflow obstruction is greater therefore the force of the huff
needs to be reduced.
3) In autogenic drainage the expiratory airflow is gently accelerated, avoiding compression of the airways.
This technique is therefore more favourably suited to patients with bronchospasm, or patients with
haemoptysis, where a gentler technique is required. In a clinical study, patients with bronchospasm
responded best to autogenic drainage [85]. As autogenic drainage requires a self-awareness of one’s own
respiratory mechanics and concentration to perform, it is generally used in teenagers or adults, unless a
caregiver is skilled in its administration.
4) PEP increases FRC during tidal volume breathing, evening out intrapulmonary distribution of
ventilation and opening up regions that are otherwise closed off [65]. It is therefore effective in both
restricted and obstructed patients. In addition, the PEP splints the airways during expiration, thereby
avoiding airway collapse, which makes it a favourable technique for patients with unstable airways.
5) Adding oscillations to expiration, either by using an oscillatory PEP device or HFCWO device, has the
added advantage of increasing mucociliary clearance [53], decreasing the viscoelastic properties of
mucus and potentially rehydrating mucus. When using oscillation devices, the clinician must consider
what method they want to use to first ventilate behind the obstructed units. Flutter uses a 3-s breath
hold; Acapella, like PEP, increases FRC, splinting airways open. HFCWO needs to be combined with
either deep inspiratory manoeuvres, 3-s breath hold or PEP.
6) Exhaling into the ERV, as used during autogenic drainage, Flutter and HFCWO assist in mobilising
secretions from the small airways, but have the potential to cause airway closure [62, 69, 71]. To avoid
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this, during these techniques, the therapist should ensure that patients adequately incorporate methods
to ventilate small airways, such as 3-s breath holds or thoracic expansion exercises.
7) A therapeutic strategy for an individual patient may involve a combination of ACTs. For example, in a
patient with unstable large airways, the use of a PEP device will enhance ventilation, but during the
huffing phase the airways may be unable to resist compression. By combining PEP with autogenic
drainage, expiratory flow rates could be increased without causing airway compression, thereby
mobilising secretions more effectively
Conclusion
The approach to care of the individual patient must be personalised. In clinical practice, more than one
ACT may be effective for a patient at a given time in their disease trajectory, and choice of technique may
then be dependent on availability and patient preference. Other considerations include cleaning and
durability of an ACT device if one is used. However, more often than not, due to the varying nature of the
underlying disease pathology and phenotypic characteristics, and taking into account the clinical,
functional, environmental and social factors of individual patients, ACTs need to be personalised to meet
patients’ specific needs. This requires a sound understanding of the physiological basis of each technique.
Examining the application of physiological principles to ACTs provides a better understanding of how to
optimise airway clearance strategies to the individual patient’s underlying pathology. This allows for both
more personalized, improved patient care. Physiological theories which support ACTs had previously been
identified [42, 43, 86]. However, this is the first review to present the physiological evidence supporting
methods that ventilate behind obstructed lung units, and modulate of expiratory airflow, and to collate this
physiological evidence in an effort to assist in translation into practice.
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